Immunohistochemistry and fluorescence in situ hybridization assessment of HER2 in clinical trials of adjuvant therapy for breast cancer (NCCTG N9831, BCIRG 006, and BCIRG 005).
scientific article published on 19 February 2013
Author/s
author:
Amylou Dueck,
Chungyeul Kim,
Edith A. Perez,
Wilma L Lingle
Wikidata